Ingrid Heinze‐Krauss

In Vitro and In Vivo Properties of Ro 63-9141, a Novel Broad-Spectrum Cephalosporin with Activity against Methicillin-Resistant Staphylococci

Paul Hebeisen, Ingrid Heinze‐Krauss, Peter Angehrn et al. · Antimicrobial Agents and Chemotherapy · 2001 · 214 citations · Full text

Life Sciences, Microbiology, Pharmacology +16

BAL9141, a Novel Extended-Spectrum Cephalosporin Active against Methicillin-Resistant <i>Staphylococcus aureus</i> in Treatment of Experimental Endocarditis

José M. Entenza, P. Hohl, Ingrid Heinze‐Krauss et al. · Antimicrobial Agents and Chemotherapy · 2002 · 91 citations · Full text

Life Sciences, Infectious Diseases, Microbiology +17

Structure-Based Design of β-Lactamase Inhibitors. 1. Synthesis and Evaluation of Bridged Monobactams

Ingrid Heinze‐Krauss, Peter Angehrn, Robert L. Charnas et al. · Journal of Medicinal Chemistry · 1998 · 75 citations · Full text

Pharmacy, Medicinal Chemistry, Pharmacology +15

Phenyl β-Methoxyacrylates:  A New Antimalarial Pharmacophore

Jawad Alzeer, Jacques Chollet, Ingrid Heinze‐Krauss et al. · Journal of Medicinal Chemistry · 2000 · 43 citations

Pharmacy, Medicinal Chemistry, Pharmacology +14

Synthesis and Structure−Activity Relationship of (Lactamylvinyl)cephalosporins Exhibiting Activity against Staphylococci, Pneumococci, and Enterococci

Ingrid Heinze‐Krauss, Peter Angehrn, Philippe Guerry et al. · Journal of Medicinal Chemistry · 1996 · 18 citations

Pharmacy, Chemistry, Medicinal Chemistry +8